Results 51 to 60 of about 1,222 (132)

An Ensemble Fuzzy-MCDM Approach for Evaluation of Approved Monkeypox Vaccines

The EuroBiotech Journal
Objective: Monkeypox, a disease caused by a deoxyribonucleic acid (DNA) based virus (MPXV) has posed global health challenges to the entire populace.
Usanase Natacha, Emegano Declan Ikechukwu, Uzun Berna, Ozsahin Dilber Uzun, Ozsahin Ilker   +4 more
doaj   +1 more source

Interdisciplinary Approach to Monkeypox Prevention: Integrating Nanobiosensors, Nanovaccines, Artificial Intelligence, Visual Arts, and Social Sciences

Small Structures, Volume 6, Issue 7, July 2025.
This illustration depicts a comprehensive strategy against monkeypox, showcasing its transmission, symptoms, and prevention. Centralized around nanomaterials and biosensors, it integrates early screening, Internet of Things, vaccination, and community involvement through collaboration among healthcare workers, scientists, researchers, social groups ...
Vishal Chaudhary, Lucky Lucky, Harsh Sable, Nikhil Bhalla   +3 more
wiley   +1 more source

Managing Monkeypox Virus Infections: A Contemporary Review [PDF]

Iranian Journal of Medical Sciences
Monkeypox is an infectious and contagious zoonotic disease caused by the Orthopoxvirus species and was first identified in Africa. Recently, this infectious disease has spread widely in many parts of the world.
Fariba Asadi Noghabi, John G. Rizk, Dheeraj Makkar, Nasibeh Roozbeh, Soleyman Ghelichpour, Aref Zarei   +5 more
doaj   +1 more source

Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application

Journal of Medical Virology, Volume 97, Issue 6, June 2025.
ABSTRACT Adeno‐associated virus (AAV) is a non‐enveloped DNA virus infecting a wide variety of species, tissues, and cell types, which is recognized as a safe and effective method for delivering therapeutic transgenes. AAV vector is the most popular viral gene delivery system in clinical delivery systems with unique and multiple advantages, such as ...
Ling Yin, Hongliang He, Hongliang Zhang, Yuhua Shang, Chengbo Fu, Songquan Wu, Tengchuan Jin   +6 more
wiley   +1 more source

Unintentional transfer of vaccinia virus associated with smallpox vaccines

Human Vaccines & Immunotherapeutics, 2013
Routine vaccination against smallpox (variola) ceased in the US in 1976. However, in 2002 limited coverage for military personnel and some healthcare workers was reinstituted. In March 2008, ACAM2000® replaced Dryvax® as the vaccine used in the United States against smallpox.
Danielle M, Tack, Kevin L, Karem, Jay R, Montgomery, Limone, Collins, Marthe G, Bryant-Genevier, Rosemary, Tiernan, Maria, Cano, Paige, Lewis, Renata J M, Engler, Inger K, Damon, Mary G, Reynolds   +10 more
openaire   +2 more sources

Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics

Advanced Healthcare Materials, Volume 14, Issue 14, May 28, 2025.
This study investigates the potential of nanohybridized niclosamide as a therapeutic agent for Mpox, focusing on enhanced bioavailability, improved antiviral efficacy, and controlled drug release achieved through nanoengineering. The research emphasizes significant advancements in formulation strategies, mechanistic insights, and therapeutic outcomes ...
N. Sanoj Rejinold, Geun‐woo Jin, Jin‐Ho Choy   +2 more
wiley   +1 more source

Molecular epidemiology, transmission and clinical features of 2022‐mpox outbreak: A systematic review

Health Science Reports, 2023
Background and Aims The 2022‐mpox outbreak has spread worldwide in a short time. Integrated knowledge of the epidemiology, clinical characteristics, and transmission of mpox are limited.
Nadim Sharif, Nazmul Sharif, Khalid J. Alzahrani, Ibrahim F. Halawani, Fuad M. Alzahrani, Isabel De la Torre Díez, Vivían Lipari, Miguel Angel López Flores, Anowar K. Parvez, Shuvra K. Dey   +9 more
doaj   +1 more source

A review of Mpox: Biological characteristics, epidemiology, clinical features, diagnosis, treatment, and prevention strategies

Exploration, Volume 5, Issue 2, April 2025.
The monkeypox virus (MPXV) has spread to many countries and caused thousands of infections all over the world. This review comprehensively introduces the biology, epidemiological characteristics of MPXV, and clinical manifestations of Mpox. The approaches for diagnosis, treatment, and prevention are also introduced, aiming to improve the general ...
Lin Jiang, Ailan Xu, Lin Guan, Yong Tang, Guangshuai Chai, Junya Feng, Yueqi Wu, Maochen Li, Chuxie Zhang, Xiaojing Liu, Xiaolong Xu, Qingquan Liu, Lihua Song, Yigang Tong, Renald Blundell, Huahao Fan   +15 more
wiley   +1 more source

Monkeypox: Prevention Strategies and Challenges: Updated Review

Health Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims The mpox virus, sometimes known as MPXV, is the cause of the disease mpox. The Monkeypox virus is a different Poxviridae family member from the orthopoxvirus (OPXV) group. Clades I and II are the two varieties of the Monkeypox virus.
Abate Wondesen Tsige, Siraye Genzeb Ayele   +1 more
wiley   +1 more source

Monkeypox Virus: WHO's Second Public Health Emergency of International Concern Within 2 Years

Microbial Biotechnology, Volume 18, Issue 4, April 2025.
The figure shows examples of zoonotic diseases and their affected populations. The red arrows indicate the path of monkeypox virus infections first from a wild animal reservoir (rodents, squirrels) as a zoonosis mostly to children in central and west Africa, followed by the 2022/3 epidemic with human‐to‐human transmission in men having sex with men and
Harald Brüssow
wiley   +1 more source